drugset / Trial / NCT02713230

Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL in Shoulder Surgery

NCT02713230

Phase 3 Completed 156 enrolled Pacira Pharmaceuticals, Inc
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study in 155 adult subjects undergoing primary unilateral total shoulder arthroplasty or rotator cuff repair with general anesthesia

Timeline

Start
2016-05-09
Primary completion
2017-07-07
Completion
2017-07-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 133 mg Other
Comparator Bupivacaine Other / unclassified 266 mg Other

Indications

No indication recorded.